These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 35384044)

  • 1. Therapeutic potentials of melatonin in the treatment of lymphoma: A review of current evidence.
    Moradian F; Pourhanifeh MH; Mehrzadi S; Karimi-Behnagh A; Hosseinzadeh A
    Fundam Clin Pharmacol; 2022 Oct; 36(5):777-789. PubMed ID: 35384044
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A phase II study of neuroimmunotherapy with subcutaneous low-dose IL-2 plus the pineal hormone melatonin in untreatable advanced hematologic malignancies.
    Lissoni P; Bolis S; Brivio F; Fumagalli L
    Anticancer Res; 2000; 20(3B):2103-5. PubMed ID: 10928160
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Melatonin and neuroblastoma: a novel therapeutic approach.
    Pourhanifeh MH; Kamali M; Mehrzadi S; Hosseinzadeh A
    Mol Biol Rep; 2021 May; 48(5):4659-4665. PubMed ID: 34061325
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An updated review of mechanistic potentials of melatonin against cancer: pivotal roles in angiogenesis, apoptosis, autophagy, endoplasmic reticulum stress and oxidative stress.
    Mehrzadi S; Pourhanifeh MH; Mirzaei A; Moradian F; Hosseinzadeh A
    Cancer Cell Int; 2021 Mar; 21(1):188. PubMed ID: 33789681
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin is a potential inhibitor of ovarian cancer: molecular aspects.
    Zare H; Shafabakhsh R; Reiter RJ; Asemi Z
    J Ovarian Res; 2019 Mar; 12(1):26. PubMed ID: 30914056
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin is an appropriate candidate for breast cancer treatment: Based on known molecular mechanisms.
    Amin N; Shafabakhsh R; Reiter RJ; Asemi Z
    J Cell Biochem; 2019 Aug; 120(8):12208-12215. PubMed ID: 31041825
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Melatonin: does it have utility in the treatment of haematological neoplasms?
    Li T; Yang Z; Jiang S; Di W; Ma Z; Hu W; Chen F; Reiter RJ; Yang Y
    Br J Pharmacol; 2018 Aug; 175(16):3251-3262. PubMed ID: 28880375
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Potential use of melatonin in skin cancer treatment: A review of current biological evidence.
    Pourhanifeh MH; Mahdavinia M; Reiter RJ; Asemi Z
    J Cell Physiol; 2019 Aug; 234(8):12142-12148. PubMed ID: 30618091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Icaritin: A Novel Natural Candidate for Hematological Malignancies Therapy.
    Yang XJ; Xi YM; Li ZJ
    Biomed Res Int; 2019; 2019():4860268. PubMed ID: 31032347
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Melatonin as a Repurposed Drug for Melanoma Treatment.
    Pathipaka R; Thyagarajan A; Sahu RP
    Med Sci (Basel); 2023 Jan; 11(1):. PubMed ID: 36649046
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Melatonin and regulation of miRNAs: novel targeted therapy for cancerous and noncancerous disease.
    Pourhanifeh MH; Mehrzadi S; Hosseinzadeh A
    Epigenomics; 2021 Jan; 13(1):65-81. PubMed ID: 33350862
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neuroprotective Mechanisms of Melatonin in Hemorrhagic Stroke.
    Wu HJ; Wu C; Niu HJ; Wang K; Mo LJ; Shao AW; Dixon BJ; Zhang JM; Yang SX; Wang YR
    Cell Mol Neurobiol; 2017 Oct; 37(7):1173-1185. PubMed ID: 28132129
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Melatonin: A new inhibitor agent for cervical cancer treatment.
    Shafabakhsh R; Reiter RJ; Mirzaei H; Teymoordash SN; Asemi Z
    J Cell Physiol; 2019 Dec; 234(12):21670-21682. PubMed ID: 31131897
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Melatonin and urological cancers: a new therapeutic approach.
    Mehrzadi MH; Hosseinzadeh A; Juybari KB; Mehrzadi S
    Cancer Cell Int; 2020; 20():444. PubMed ID: 32943992
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Melatonin as a Pleiotropic Molecule with Therapeutic Potential for Type 2 Diabetes and Cancer.
    Wojcik M; Krawczyk M; Wojcik P; Cypryk K; Wozniak LA
    Curr Med Chem; 2017 Nov; 24(35):3829-3850. PubMed ID: 28721827
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Role of Melatonin in Colorectal Cancer.
    Iravani S; Eslami P; Dooghaie Moghadam A; Moazzami B; Mehrvar A; Hashemi MR; Mansour-Ghanaei F; Mansour-Ghanaei A; Majidzadeh-A K
    J Gastrointest Cancer; 2020 Sep; 51(3):748-753. PubMed ID: 31792737
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The inhibitory effect of melatonin on human prostate cancer.
    Shen D; Ju L; Zhou F; Yu M; Ma H; Zhang Y; Liu T; Xiao Y; Wang X; Qian K
    Cell Commun Signal; 2021 Mar; 19(1):34. PubMed ID: 33722247
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Melatonin and gastrointestinal cancers: Current evidence based on underlying signaling pathways.
    Pourhanifeh MH; Mehrzadi S; Kamali M; Hosseinzadeh A
    Eur J Pharmacol; 2020 Nov; 886():173471. PubMed ID: 32877658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of Melatonin on Endoplasmic Reticulum-Mitochondrial Crosstalk in Stroke.
    Abolhasanpour N; Alihosseini S; Golipourkhalili S; Badalzadeh R; Mahmoudi J; Hosseini L
    Arch Med Res; 2021 Oct; 52(7):673-682. PubMed ID: 33926763
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular and Biological Functions of Melatonin in Endometrial Cancer.
    Dana PM; Sadoughi F; Mobini M; Shafabakhsh R; Chaichian S; Moazzami B; Chamani M; Asemi Z
    Curr Drug Targets; 2020; 21(5):519-526. PubMed ID: 31560286
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.